Implantable Tibial Nerve Stimulation Devices for Treatment of Overactive Bladder

home / uroview / treatment-of-overactive-bladder

This Uroview features discussion between Dr. Alexandra Rogers and Dr. Scott MacDiarmid about current and emerging treatments for overactive bladder, with a focus on implantable tibial nerve stimulation devices in this space.

overactive bladder

EP. 1: Overactive Bladder Prevalence and Impact

Alexandra Rogers, MD;Scott MacDiarmid, MD, FRCPSC
March 2nd 2022

Dr Alex Rogers and Dr Scott MacDiarmid discuss overactive bladder (OAB) prevalence and diagnosis and its impact on quality of life.

overactive bladder

EP. 2: Overactive Bladder Treatment

Alexandra Rogers, MD;Scott MacDiarmid, MD, FRCPSC
March 2nd 2022

Drs MacDiarmid and Rogers discuss treatment for OAB and the use of care pathways to treat patients.

overactive bladder

EP. 3: Third-Line Treatments for Overactive Bladder

Scott MacDiarmid, MD, FRCPSC;Alexandra Rogers, MD
March 9th 2022

Overactive bladder experts discuss when they move from one treatment to another, and share pros and cons of available third-line treatments.

overactive bladder

EP. 4: Tibial Nerve Stimulation Devices for OAB Treatment

Scott MacDiarmid, MD, FRCPSC;Alexandra Rogers, MD
March 9th 2022

Experts discuss tibial nerve stimulation, an emerging treatment for OAB.

overactive bladder

EP. 5: Implantable Tibial Nerve Stimulation: eCoin

Alexandra Rogers, MD;Scott MacDiarmid, MD, FRCPSC
March 16th 2022

Drs Rogers and MacDiarmid discuss data from feasibility and pivotal studies with eCoin, a tibial nerve stimulation device, and how it compares to other third-line treatments.

overactive bladder treatment

EP. 6: Reimplantation of Tibial Nerve Stimulation Device (eCoin)

Scott MacDiarmid, MD, FRCPSC;Alexandra Rogers, MD
March 16th 2022

OAB experts share their experience with reimplantation of a tibial nerve stimulation device (eCoin).

urologist

EP. 7: Future of Overactive Bladder Treatment

Scott MacDiarmid, MD, FRCPSC;Scott MacDiarmid, MD, FRCPSC
March 23rd 2022

Drs MacDiarmid and Rogers discuss barriers to OAB treatments and therapies on the horizon.

© 2024 MJH Life Sciences

All rights reserved.